Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Rappazzo CG, Tse LV, Kaku CI, Wrapp D, et al. Science 2021 Jan 25. pii: science.abf4830. doi: 10.1126/science.abf4830.

Read + Share

Amedeo Smart

Independent Medical Education

Rappazzo CG, Tse LV, Kaku CI, Wrapp D, et al. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science 2021 Jan 25. pii: science.abf4830. doi: 10.1126/science.abf4830.
PMID: 33495307